Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
Open accessAbstract
N-methyl-D-aspartate receptors (NMDARs) represent a subclass of glutamate receptors that play a critical role in neuronal development and physiology. We report here the generation of mice expressing only 5% of normal levels of the essential NMDAR1 (NR1) subunit. Unlike NR1 null mice, these mice survive to adulthood and display behavioral abnormalities, including increased motor activity and stereotypy and deficits in social and sexual interactions. These behavioral alterations are similar to those observed in pharmacologically induced animal models of schizophrenia and can be ameliorated by treatment with haloperidol or clozapine, antipsychotic drugs that antagonize dopaminergic and serotonergic receptors. These findings support a model in which reduced NMDA receptor activity results in schizophrenic-like behavior and reveals how pharmacological manipulation of monoaminergic pathways can affect this phenotype.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Observational findings in some of these behavioral domains have been reported in some targeted gene mutations, e.g. deficits in social interaction within the home cage have been reported for mice deficient in the dishevelled-1 gene or the NMDA NR1 subunit.
“Observational findings in some of these behavioral domains have been reported in some targeted gene mutations, e.g.deficits in social interaction within the home cage have been reported for mice deficient in the dishevelled-1 gene (Lijam et al. 1997) or the NMDA NR1 subunit (Mohn et al. 1999).”
From Sociability and preference for social novelty in five inbred strains: an approach to assess autistic‐like behavior in mice (2004) · cites this paper as Mohn et al. 1999
NMDAR antagonism during the first 2 postnatal weeks in rodents induces long-lasting behavioural and cognitive disturbances relevant to the schizophrenia phenotype that extend into adolescence and adulthood.
“In supporting of this notion, NMDAR antagonism during an equivalent period in rodents (first 2 post-natal weeks) induces long-lasting behavioural and cognitive disturbances that are relevant to the schizophrenia phenotype and which extend into adolescence and adulthood 10,27 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [27]
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859 · see citing works
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258 · see citing works
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904 · see citing works
Heteromeric NMDA receptors: molecular and functional distinction of subtypes
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541 · see citing works
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476 · see citing works
Self-citationAntipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622 · see citing works
Crawley, J. N., Belknap, J. K., Collins, A. C., Crabbe, J. C., Frankel, W. N., Henderson, N. D., HITZEMANN, R. J., Maxson, S. C., Miner, L. L., Silva, A. J., et al. (1997) · Psychopharmacology · doi:10.1007/s002130050327 · Cited by 1,372 · see citing works
Molecular diversity of the NMDA receptor channel
Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Hisashi, M., Kumanishi, T., Arakawa, M., et al. (1992) · Nature · doi:10.1038/358036a0 · Cited by 1,346 · see citing works
HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells
Hooper, M., Hardy, K., Handyside, A. H., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,218 · see citing works
Carlsson, M. L., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,086 · see citing works
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
Andén, N., Butcher, S. G., CORRODI, H., Fuxé, K., & Ungerstedt, U. (1970) · European Journal of Pharmacology · doi:10.1016/0014-2999(70)90006-3 · Cited by 1,026 · see citing works
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006 · see citing works
Study of a New Schizophrenomimetic Drug—Sernyl
LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921 · see citing works
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885 · see citing works
Self-citationReduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit
Sakimura, K., Kutsuwada, T., Ito, I., Manabe, T., Takayama, C., Kushiya, E., Yagi, T., Aizawa, S., Inoue, Y., Sugiyama, H., et al. (1995) · Nature · doi:10.1038/373151a0 · Cited by 859 · see citing works
Recent Advances in the Molecular Biology of Dopamine Receptors
Gingrich, J. A., & Caron, M. G. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.001503 · Cited by 785 · see citing works
Self-citationMalhotra, A. K. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00036-5 · Cited by 681 · see citing works
Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A
Das, S., Sasaki, Y., Rothe, T., Premkumar, L. S., Takasu, M. A., Crandall, J. E., Dikkes, P., Conner, D. A., Posina, V. R., Cheung, W., et al. (1998) · Nature · doi:10.1038/30748 · Cited by 611 · see citing works
The Glutamatergic Dysfunction Hypothesis for Schizophrenia
Coyle, J. T. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609017192 · Cited by 568 · see citing works
Kutsuwada, T., Sakimura, K., Manabe, T., Takayama, C., Katakura, N., Kushiya, E., Natsume, R., Watanabe, M., Inoue, Y., Yagi, T., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80051-3 · Cited by 498 · see citing works
Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death
Forrest, D., Yuzaki, M., Soares, H. D., Ng, L., Luk, D. C., Sheng, M., Stewart, C. L., Morgan, J. I., Connor, J. A., & Curran, T. (1994) · Neuron · doi:10.1016/0896-6273(94)90350-6 · Cited by 491 · see citing works
Mutant Mice and Neuroscience: Recommendations Concerning Genetic Background
Silva, A. J., Simpson, E. M., Takahashi, J. S., Lipp, H.-P., Nakanishi, S., Wehner, J. M., Giese, K. P., Tully, T., Abel, T., Chapman, P. F., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80958-7 · Cited by 479 · see citing works
Li, Y., Erzurumlu, R. S., Chen, C., Jhaveri, S., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90108-2 · Cited by 469 · see citing works
Kelly, M. A., Rubinstein, M., Phillips, T. J., Lessov, C. N., Burkhart‐Kasch, S., Zhang, G., Bunzow, J. R., Fang, Y., Gerhardt, G. A., Grandy, D. K., et al. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03470.1998 · Cited by 447 · see citing works
The Mechanism of Action of Novel Antipsychotic Drugs
Meltzer, H. Y. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.263 · Cited by 412 · see citing works
Dombrowicz, D., Flamand, V., Brigman, K. K., Koller, B. H., & Kinet, J.-P. (1993) · Cell · doi:10.1016/0092-8674(93)90540-7 · Cited by 399 · see citing works
Self-citationSchizophrenia and Glutamatergic Transmission
Tamminga, C. A. (1998) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v12.i1-2.20 · Cited by 385 · see citing works
Wang, Y.-M., Gainetdinov, R. R., Fumagalli, F., Xu, F., Jones, S. R., Bock, C. B., Miller, G. W., Wightman, R. M., & Caron, M. G. (1997) · Neuron · doi:10.1016/s0896-6273(00)80419-5 · Cited by 376 · see citing works
Self-citationGlutamate receptors: brain function and signal transduction
Nakanishi, S., Nakajima, Y., Masu, M., Ueda, Y., Nakahara, K., Watanabe, D., Yamaguchi, S., Kawabata, S., & Okada, M. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00033-7 · Cited by 340 · see citing works
Amphetamine psychosis: Behavioral and biochemical aspects
Angrist, B., Sathananthan, G., Wilk, S., & Gershon, S. (1974) · Journal of Psychiatric Research · doi:10.1016/0022-3956(74)90064-8 · Cited by 326 · see citing works
Ellison, G. D. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00014-g · Cited by 304 · see citing works
Griffith, J. D. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750200001001 · Cited by 270 · see citing works
Antipsychotic agents antagonize non-competitiveN-methyl-d-aspartate antagonist-induced behaviors
Corbett, R., Camacho, F., Woods, A. T., Kerman, L. L., Fishkin, R. J., Brooks, K., & Dunn, R. W. (1995) · Psychopharmacology · doi:10.1007/bf02246146 · Cited by 248 · see citing works
Hoffman, D., & Donovan, H. (1995) · Psychopharmacology · doi:10.1007/bf02246184 · Cited by 224 · see citing works
NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus
Impérato, A., Scrocco, M. G., Bacchi, S., & Angelucci, L. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90387-l · Cited by 219 · see citing works
Gleason, S. D., & Shannon, H. E. (1997) · Psychopharmacology · doi:10.1007/s002130050165 · Cited by 216 · see citing works
The NMDA Antagonist Model for Schizophrenia: Promise and Pitfalls
Abi-Saab, W., D'Souza, D., Moghaddam, B., & Krystal, J. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979354 · Cited by 208 · see citing works
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
Carlsson, A., Hansson, L. O., Waters, N., & Carlsson, M. L. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00228-2 · Cited by 187 · see citing works
New Antipsychotics: Classification, Efficacy, and Adverse Effects
Gerlach, J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.289 · Cited by 183 · see citing works
Unusual behavioral phenotypes of inbred mouse strains
Crawley, J. N. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)20021-9 · Cited by 179 · see citing works
Reduced spontaneous activity of mice defective in the ε4 subunit of the NMDA receptor channel
Ikeda, K., Araki, K., Takayama, C., Inoue, Y., Yagi, T., Aizawa, S., & Mishina, M. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00107-4 · Cited by 148 · see citing works
Miller, D. W., & Abercrombie, E. D. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02144-2 · Cited by 146 · see citing works
Ebralidze, A. K., Rossi, D. J., Tonegawa, S., & Slater, N. T. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-16-05014.1996 · Cited by 136 · see citing works
Effects of atypical antipsychotic agents on social behavior in rodents
Corbett, R., Hartman, H. B., Kerman, L. L., Woods, A. T., Strupczewski, J. T., Helsley, G. C., Conway, P. C., & Dunn, R. W. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90079-9 · Cited by 127 · see citing works
Social Class, Marriage, and Fertility in Schizophrenia
Saugstad, L. (1989) · Schizophrenia Bulletin · doi:10.1093/schbul/15.1.9 · Cited by 122 · see citing works
Clozapine: an atypical antipsychotic agent.
Ereshefsky, L., Watanabe, & Tk, T.-J. (1989) · PubMed · Cited by 102 · see citing works
Glutamate in schizophrenia: clinical and research implications
GOFF, D. C., & Wine, L. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00079-0 · Cited by 93 · see citing works
Martin, P., Waters, N., Schmidt, C. J., Carlsson, A., & Carlsson, M. L. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050064 · Cited by 86 · see citing works
Knable, M. B., Hyde, T. M., Herman, M. M., Carter, J. M., Bigelow, L. B., & Kleinman, J. E. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90593-2 · Cited by 72 · see citing works
Pierce, R. C., Meil, W. M., & Kalivas, P. W. (1997) · Psychopharmacology · doi:10.1007/s002130050390 · Cited by 70 · see citing works
Fertility of psychiatric first admissions in Norway 1936–1975
ÖDegårrd, Ö. (1980) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1980.tb00609.x · Cited by 68 · see citing works
Protein kinase and phosphatase activity regulate the form of synaptic plasticity expressed
Coussens, C., & Teyler, T. J. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199610)24:2 · Cited by 55 · see citing works
D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects
Lahti, R. A., Roberts, R. C., Conley, R. R., Cochrane, E. V., Mutin, A., & Tamminga, C. A. (1996) · Neuroreport · doi:10.1097/00001756-199608120-00016 · Cited by 45 · see citing works
Fertility in schizophrenia: results from a contemporary US cohort
Nimgaonkar, V. L., Ward, S. E., Agarde, H., Weston, N., & Ganguli, R. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09647.x · Cited by 39 · see citing works
Ban, T. A., Guy, W., & Wh, W. (1984) · PubMed · Cited by 28 · see citing works
Nieoullon, A., Kerkerian, L., & Dusticier, N. (1983) · Experimental brain research. Supplementum · doi:10.1007/978-3-642-68915-4_5 · Cited by 28 · see citing works
Hyttel, J. (1978) · Psychopharmacology · doi:10.1007/bf00426624 · Cited by 26 · see citing works
Clozapine promotes approach-oriented behavior in male mice.
Dixon, A. K., Huber, C., & Lowe, D. (1994) · PubMed · Cited by 26 · see citing works
PCP site 2: A high affinity MK-801-insensitive phencyclidine binding site
Rothman, R. B. (1994) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(94)90022-1 · Cited by 18 · see citing works
Nankai, M., Klarica, M., Fage, D., & Carter, C. J. (1996) · Neurochemistry International · doi:10.1016/0197-0186(96)00010-1 · Cited by 16 · see citing works
Genetic manipulation of embryonic stem cells
Mohn, A. R., & Koller, B. H. (1996) · doi:10.1093/oso/9780199634811.003.0005 · Cited by 11 · see citing works
Self-citationAkunne, H. C., Johannessen, J. N., de Costa, B. R., Rice, K. C., & Rothman, R. B. (1992) · Neurochemical Research · doi:10.1007/bf00966668 · Cited by 8 · see citing works
Timing of induced ovulation in C.B-17/Icr-scid/scid and B6SJLF1 mice.
Masters, W. G., & Wheeler, M. B. (1996) · PubMed · Cited by 7 · see citing works
Flagged first, then by citations
1 of the 64 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70310-1 · Cited by 3,165 · see citing works
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763 · see citing works
Self-citationNMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
Paoletti, P., Bellone, C., & Zhou, Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3504 · Cited by 2,523 · see citing works
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Dalmau, J. O., Lancaster, E., Martínez‐Hernández, E., Rosenfeld, M. R., & Balice‐Gordon, R. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,428 · see citing works
NMDA receptor subunits: diversity, development and disease
Cull-Candy, S., Brickley, S., & Farrant, M. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00215-4 · Cited by 1,694 · see citing works
Neuregulin 1 and Susceptibility to Schizophrenia
Stefánsson, H., Pétursson, H., Sigurðsson, E., Steinthórsdóttir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,671 · see citing works
Moy, S. S., Nadler, J. J., Perez, A., Barbaro, R. P., Johns, J. M., Magnuson, T. R., Piven, J., & Crawley, J. N. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-1848.2004.00076.x · Cited by 1,545 · see citing works
Astrocyte Control of Synaptic Transmission and Neurovascular Coupling
Haydon, P. G., & Carmignoto, G. (2006) · Physiological Reviews · doi:10.1152/physrev.00049.2005 · Cited by 1,326 · see citing works
NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders
Lau, C. G., & Zukin, R. S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2153 · Cited by 1,159 · see citing works
Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-10.2010 · Cited by 1,143 · see citing works
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010 · see citing works
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
GOFF, D. C., & Coyle, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1367 · Cited by 914 · see citing works
NMDA receptor subunits: function and pharmacology
PAOLETTI, P., & NEYTON, J. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.011 · Cited by 887 · see citing works
Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H., Rosa, P. L., et al. (2002) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.182412499 · Cited by 541 · see citing works
Catching up on schizophrenia: natural history and neurobiology.
Lewis, D. A., & Lieberman, J. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)00111-2 · Cited by 71 · see citing works
Ross, C. A., Margolis, R. L., Reading, S. A. J., Pletnikov, M. V., & Coyle, J. T. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.015 · Cited by 697 · see citing works
Carlén, M., Meletis, K., Siegle, J. H., Cardin, J. A., Futai, K., Vierling-Claassen, D., Rühlmann, C., Jones, S. R., Deisseroth, K., Sheng, M., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.31 · Cited by 669 · see citing works
The Acid-Activated Ion Channel ASIC Contributes to Synaptic Plasticity, Learning, and Memory
Wemmie, J. A., Chen, J., Askwith, C. C., Hruska-Hageman, A. M., Price, M. P., Nolan, B. C., Yoder, P. G., Lamani, E., Hoshi, T., Freeman, J. H., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00661-x · Cited by 658 · see citing works
To Model a Psychiatric Disorder in Animals Schizophrenia As a Reality Test
Lipska, B. K. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00137-8 · Cited by 650 · see citing works
Dalmau, J. O., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 631 · see citing works
Schizophrenia: Diverse Approaches to a Complex Disease
Sawa, A., & Snyder, S. H. (2002) · Science · doi:10.1126/science.1070532 · Cited by 599 · see citing works
Lieberman, J. A., Perkins, D. O., Belger, A., Chakos, M., Jarskog, F., Boteva, K., & Gilmore, J. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01303-8 · Cited by 593 · see citing works
Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers
Umbricht, D., Schmid, L., Koller, R., Vollenweider, F. X., Hell, D., & Javitt, D. C. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.12.1139 · Cited by 583 · see citing works
Glutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577 · see citing works
Molecular Mechanisms of Glutamate Receptor-Mediated Excitotoxic Neuronal Cell Death
Sattler, R., & Tymianski, M. (2001) · Molecular Neurobiology · doi:10.1385/mn:24:1-3:107 · Cited by 537 · see citing works
Glutamate as a therapeutic target in psychiatric disorders
Javitt, D. C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001551 · Cited by 524 · see citing works
Akt/GSK3 Signaling in the Action of Psychotropic Drugs
Beaulieu, J., Gainetdinov, R. R., & Caron, M. G. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 523 · see citing works
Self-citationFurukawa, H., & Gouaux, E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg303 · Cited by 510 · see citing works
GABAergic interneuron origin of schizophrenia pathophysiology
Nakazawa, K., Zsiros, V., Jiang, Z., Nakao, K., Kolata, S., Zhang, S., & Belforte, J. E. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.022 · Cited by 498 · see citing works
Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice
Planagumà, J., Leypoldt, F., Mannara, F., Cuesta, J., Martín‐García, E., Aguilar, E., Titulaer, M. J., Petit‐Pedrol, M., Jain, A., Balice‐Gordon, R. J., et al. (2014) · Brain · doi:10.1093/brain/awu310 · Cited by 489 · see citing works
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia
Miyakawa, T., Leiter, L. M., Gerber, D. J., Gainetdinov, R. R., Sotnikova, T. D., Zeng, H., Caron, M. G., & Tonegawa, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432926100 · Cited by 489 · see citing works
Self-citationKorotkova, T., Fuchs, E. C., Ponomarenko, A., von Engelhardt, J., & Monyer, H. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.017 · Cited by 480 · see citing works
Roceri, M., Hendriks, W. J. A. J., Racagni, G., Ellenbroek, B. A., & Riva, M. A. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001036 · Cited by 465 · see citing works
Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies
Marsman, A., van den Heuvel, M. P., Klomp, D. W. J., Kahn, R. S., Luijten, P. R., & Hulshoff Pol, H. E. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr069 · Cited by 457 · see citing works
Fatemi, S. H., Earle, J. A., & McMenomy, T. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000783 · Cited by 447 · see citing works
Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia
Phillips, W. A., & Silverstein, S. M. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03000025 · Cited by 445 · see citing works
Linking neurodevelopmental and synaptic theories of mental illness through DISC1
Brandon, N. J., & Sawa, A. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3120 · Cited by 422 · see citing works
GABAergic Interneurons Shape the Functional Maturation of the Cortex
Le Magueresse, C., & Monyer, H. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.011 · Cited by 425 · see citing works
Camargo, L. M., Collura, V, Rain, J.-C., Mizuguchi, K., Hermjakob, H., Kerrien, S., Bonnert, T. P., Whiting, P. J., & Brandon, N. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001880 · Cited by 405 · see citing works
Bringing Order to the Glutamate Chaos in Schizophrenia
Moghaddam, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00757-8 · Cited by 403 · see citing works
MicroRNAs in neuronal function and dysfunction
Im, H.-I., & Kenny, P. J. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.01.004 · Cited by 399 · see citing works
Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia
Corfas, G., Roy, K., & Buxbaum, J. D. (2004) · Nature Neuroscience · doi:10.1038/nn1258 · Cited by 388 · see citing works
Identification of PSD-95 as a Regulator of Dopamine-Mediated Synaptic and Behavioral Plasticity
Yao, W., Gainetdinov, R. R., Arbuckle, M. I., Sotnikova, T. D., Cyr, M., Beaulieu, J., Torres, G. E., Grant, S. G. N., & Caron, M. G. (2004) · Neuron · doi:10.1016/s0896-6273(04)00048-0 · Cited by 380 · see citing works
Self-citationHashimoto, H., Shintani, N., Tanaka, K., Mori, W., Hirose, M., Matsuda, T., Sakaue, M., Miyazaki, J., Niwa, H., Tashiro, F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231094498 · Cited by 373 · see citing works
Gao, X.-M., Sakai, K., Roberts, R. C., Conley, R. R., Dean, B., & Tamminga, C. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1141 · Cited by 371 · see citing works
Schizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder?
Powell, C. M., & Miyakawa, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.008 · Cited by 368 · see citing works
Wenthold, R. J., Prybylowski, K., Standley, S., Sans, N., & Petralia, R. S. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135803 · Cited by 363 · see citing works
Acute mechanisms underlying antibody effects in anti–N‐methyl‐D‐aspartate receptor encephalitis
Moscato, E. H., Peng, X., Jain, A., Parsons, T. D., Dalmau, J. O., & Balice‐Gordon, R. J. (2014) · Annals of Neurology · doi:10.1002/ana.24195 · Cited by 361 · see citing works
Hamdan, F. F., Gauthier, J., Araki, Y., Lin, D.-T., Yoshizawa, Y., Higashi, K., Park, A.-R., Spiegelman, D., Dobrzeniecka, S., Piton, A., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.02.001 · Cited by 349 · see citing works
van den Buuse, M. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp132 · Cited by 340 · see citing works
PDZ Domain Suppression of an ER Retention Signal in NMDA Receptor NR1 Splice Variants
Standley, S., Roche, K. W., McCallum, J. D., Sans, N., & Wenthold, R. J. (2000) · Neuron · doi:10.1016/s0896-6273(00)00161-6 · Cited by 346 · see citing works
Retrotransposons as epigenetic mediators of phenotypic variation in mammals
Whitelaw, E., & Martin, D. I. K. (2001) · Nature Genetics · doi:10.1038/86850 · Cited by 353 · see citing works
Roles of NMDA receptor activity and nitric oxide production in brain development
Contestabile, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00018-7 · Cited by 338 · see citing works
Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.
Bubeníková-Valešová, V., Horáček, J., Vrajová, M., & Höschl, C. (2008) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.03.012 · Cited by 330 · see citing works
Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment
Konradi, C., & Heckers, S. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00328-5 · Cited by 336 · see citing works
PTHrP and Indian hedgehog control differentiation of growth plate chondrocytes at multiple steps
Kobayashi, T., Chung, U., Schipani, E., Starbuck, M. W., Karsenty, G., Katagiri, T., GOAD, D. L., Lanske, B., & Kronenberg, H. M. (2002) · Development · doi:10.1242/dev.129.12.2977 · Cited by 320 · see citing works
Roy, K., Murtie, J. C., El-Khodor, B. F., Edgar, N., Sardi, S. P., Hooks, B. M., Benoit-Marand, M., Chen, C., Moore, H., O'Donnell, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702157104 · Cited by 319 · see citing works
Modeling madness in mice: one piece at a time
Arguello, P. A., & Gogos, J. A. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.023 · Cited by 309 · see citing works
Miller, B. H., Zeier, Z., Xi, L., Lanz, T. A., Deng, S., Strathmann, J., Willoughby, D., Kenny, P. J., Elsworth, J. D., Lawrence, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113793109 · Cited by 309 · see citing works
d ‐Amino acids in the brain: d ‐serine in neurotransmission and neurodegeneration
Wolosker, H., Dumin, E., Balan, L., & Foltyn, V. N. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06515.x · Cited by 309 · see citing works
Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis
Hardingham, G. E., & Do, K. Q. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.19 · Cited by 304 · see citing works
Young, J. W., Powell, S. B., Risbrough, V. B., Marston, H. M., & Geyer, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.004 · Cited by 299 · see citing works
NMDA receptors in nervous system diseases
Zhou, Q., & Sheng, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.030 · Cited by 293 · see citing works
Sun, Y., Savanenin, A., Reddy, P. H., & Liu, Y. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103501200 · Cited by 297 · see citing works
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction
Kocerha, J., Faghihi, M. A., López-Toledano, M. A., Huang, J., Ramsey, A. J., Caron, M. G., Salès, N., Willoughby, D., Elmén, J., Hansen, H. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805854106 · Cited by 292 · see citing works
Self-citationSchizophrenia: from phenomenology to neurobiology
Wong, A. H. C., & Tol, H. H. M. V. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00035-6 · Cited by 282 · see citing works
Gandal, M. J., Edgar, J. C., Klook, K., & Siegel, S. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.007 · Cited by 269 · see citing works
Tremolizzo, L., Doueiri, M.-S., Dong, E., Grayson, D. R., Davis, J. M., Pinna, G., Tueting, P. A., Rodriguez‐Menendez, V., Costa, E., & Guidotti, A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.046 · Cited by 257 · see citing works
Glutamate Synapses in Human Cognitive Disorders
Volk, L. J., Chiu, S., Sharma, K., & Huganir, R. L. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033821 · Cited by 246 · see citing works
Potentiation of NMDA receptor currents by dopamine D 1 receptors in prefrontal cortex
Chen, G., Greengard, P., & Yan, Z. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308618100 · Cited by 243 · see citing works
NMDA receptor regulation of memory and behavior in humans
Newcomer, J. W., & Krystal, J. (2001) · Hippocampus · doi:10.1002/hipo.1069 · Cited by 258 · see citing works
Rujescu, D., Bender, A., Keck, M. E., Hartmann, A. M., Ohl, F., Ræder, H., Giegling, I., Genius, J., McCarley, R. W., Möller, H., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.029 · Cited by 239 · see citing works
NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
Snyder, M. A., & Gao, W. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00031 · Cited by 237 · see citing works
Beaulieu, J. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110011 · Cited by 237 · see citing works
Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
Weickert, C. S., Fung, S. J., Catts, V. S., Schofield, P. R., Allen, K. M., Moore, L., Newell, K. A., Pellen, D., Huang, X.-F., Catts, S. V., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.137 · Cited by 234 · see citing works
Wang, C., McInnis, J., Ross-Sanchez, M., Shinnick‐Gallagher, P., Wiley, J. L., & Johnson, K. M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00384-0 · Cited by 234 · see citing works
Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice
Spielewoy, C., Roubert, C., Hamon, M., Nosten‐Bertrand, M., Betancur, C., & Bruno Giros, A. (2000) · Behavioural Pharmacology · doi:10.1097/00008877-200006000-00011 · Cited by 228 · see citing works
O’Tuathaigh, C. M. P., Babovic, D., O’Sullivan, G. J., Clifford, J. J., Tighe, O., Croke, D. T., Harvey, R. P., & Waddington, J. L. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.03.051 · Cited by 230 · see citing works
Kotecha, S. A., Oak, J. N., Jackson, M. F., Perez, Y., Orser, B. A., Tol, H. H. M. V., & MacDonald, J. F. (2002) · Neuron · doi:10.1016/s0896-6273(02)00859-0 · Cited by 227 · see citing works
Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses
Law, A. J., & Deakin, J. F. W. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00043 · Cited by 227 · see citing works
Serotonin 5-HT1A Receptors Regulate NMDA Receptor Channels through a Microtubule-Dependent Mechanism
Yuen, E. Y. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1187-05.2005 · Cited by 225 · see citing works
Groc, L., Choquet, D., Stephenson, F. A., Verrier, D., Manzoni, O. J., & Chavis, P. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1772-07.2007 · Cited by 225 · see citing works
Millan, M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2199-1 · Cited by 226 · see citing works
The dopamine D3 receptor, a quarter century later
Sokoloff, P., & Foll, B. L. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13390 · Cited by 223 · see citing works
The Gut-Brain Axis, BDNF, NMDA and CNS Disorders
Maqsood, R., & Stone, T. W. (2016) · Neurochemical Research · doi:10.1007/s11064-016-2039-1 · Cited by 223 · see citing works
A phenotypic and molecular characterization of the <i>fmr1‐tm1Cgr</i> Fragile X mouse
Yan, Q. J., Asafo‐Adjei, P. K., Arnold, H. M., Brown, R. E., & Bauchwitz, R. P. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2004.00087.x · Cited by 213 · see citing works
Neurogenetics of Aggressive Behavior: Studies in Rodents
Takahashi, A., & Miczek, K. A. (2013) · Current topics in behavioral neurosciences · doi:10.1007/7854_2013_263 · Cited by 212 · see citing works
Regulation of Dopamine D1 Receptor Function by Physical Interaction with the NMDA Receptors
Pei, L., Lee, F. J. S., Moszczyńska, A., Vukusic, B., & Liu, F. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3922-03.2004 · Cited by 205 · see citing works
Erythropoietin: a candidate compound for neuroprotection in schizophrenia
Ehrenreich, H., Degner, D., Meller, J., Brines, M. L., Béhé, M. P., Hasselblatt, M., Woldt, H., Falkai, P., Knerlich‐Lukoschus, F., Jacob, S., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001442 · Cited by 209 · see citing works
The Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities
Carpenter, W. T., & Koenig, J. I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301639 · Cited by 210 · see citing works
Linking Hebb's coincidence-detection to memory formation
Tsien, J. Z. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00070-2 · Cited by 205 · see citing works
Gandal, M. J., Sisti, J., Klook, K., Ortinski, P. I., Leitman, V, Liang, Y., Thieu, T., Anderson, R., Pierce, R. C., Jonak, G., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.69 · Cited by 204 · see citing works
Cell Type-Specific Development of NMDA Receptors in the Interneurons of Rat Prefrontal Cortex
Wang, H.-X., & Gao, W. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.20 · Cited by 198 · see citing works
Genetic animal models: focus on schizophrenia
Gainetdinov, R. R., Mohn, A. R., & Caron, M. G. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01886-5 · Cited by 201 · see citing works
Self-citationSocial Interaction Deficits Caused by Chronic Phencyclidine Administration are Reversed by Oxytocin
Lee, P. R., Brady, D. L., Shapiro, R. A., Dorsa, D. M., & Koenig, J. I. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300722 · Cited by 199 · see citing works
Revel, F. G., Moreau, J., Gainetdinov, R. R., Ferragud, A., Velázquez-Sánchez, C., Sotnikova, T. D., Morairty, S. R., Harmeier, A., Zbinden, K. G., Norcross, R. D., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.014 · Cited by 196 · see citing works
Self-citationDevelopment of a mouse test for repetitive, restricted behaviors: Relevance to autism
Moy, S. S., Nadler, J. J., Poe, M. D., Nonneman, R. J., Young, N. B., Koller, B. H., Crawley, J. N., Duncan, G. E., & Bodfish, J. W. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.10.029 · Cited by 195 · see citing works
Self-citationDuncan, G. E., Moy, S. S., Perez, A., Eddy, D. M., Zinzow-Kramer, W. M., Lieberman, J. A., Snouwaert, J. N., & Koller, B. H. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.01.008 · Cited by 194 · see citing works
Self-citationd-Amino acids in the central nervous system in health and disease
Fuchs, S. A., Berger, R., Klomp, L. W. J., & de Koning, T. J. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.03.003 · Cited by 192 · see citing works
Matta, J. A., Ashby, M. C., Sanz-Clemente, A., Roche, K. W., & Isaac, J. T. R. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.045 · Cited by 189 · see citing works
- Authors
- Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Koller, Beverly H
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1999-08
- Volume
- 98
- Issue
- 4
- Pages
- 427-436
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2164674870
- Cited by
- 1,075
- References
- 64
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 19 · 2023: 17 · 2022: 28 · 2021: 26 · 2020: 26 · 2019: 28 · 2018: 29 · 2017: 27 · 2016: 46 · 2015: 40 · 2014: 39 · 2013: 42 · 2012: 45
- FWCI
- 24.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (T32GM007092, T32 GM07092)
- National Institute of Neurological Disorders and Stroke (NS-19576, R01NS019576)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- NMDA receptor, NR1 subunit, schizophrenia, mouse model, motor activity, stereotypy, social interaction deficits, antipsychotic drugs, haloperidol, clozapine, monoaminergic pathways, glutamate receptors
- MeSH terms
- Animals, Antisocial Personality Disorder, Behavior, Animal, Clozapine, Disease Models, Animal, Female, Haloperidol, Male, Motor Activity, Phencyclidine, Schizophrenic Psychology, Serotonin Antagonists, Sexual Behavior, Animal, Social Behavior, Stereotyped Behavior, Antipsychotic Agents, Receptors, N-Methyl-D-Aspartate, Dizocilpine Maleate, Mice, Knockout, Dopamine Antagonists, Excitatory Amino Acid Antagonists, Glutamic Acid, Calcium Signaling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review